Safety and efficacy of percutaneous microwave ablation for post-procedural haemostasis: a bi-central retrospective study focusing on safety and efficacy.


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
01 Feb 2020
Historique:
pubmed: 4 12 2019
medline: 6 2 2020
entrez: 4 12 2019
Statut: ppublish

Résumé

To review safety and efficacy of percutaneous microwave ablation (MWA) for post-procedural haemostasis. Institutional databases retrospective research identified 10 cases of iatrogenic bleeding who underwent percutaneous MWA for post-procedural haemostasis. Ultrasound examination with Doppler and contrast enhancement identified a source of active bleeding prior to ablation; additionally they were used as guiding modality for antenna insertion whilst, post-ablation, assessed the lack of active extravasation. Target locations included liver intercostal space spleen and thyroid gland. Technical success was defined as positioning of the antenna on the desired location. Treatment end point was considered the disappearance of active extravasation in both Doppler imaging and contrast-enhanced ultrasound. Technical success ( Our limited experience reports preliminary data showing that MWA could be added in the armamentarium of percutaneous therapies for iatrogenic bleeding. More prospective studies with larger patient samples are necessary for verification of this technique as well as for drawing broader conclusions in order to evaluate the place of percutaneous ablation in the treatment algorithm of haemorrhage. Percutaneous ablation might have a role in haemostasis in well-selected cases.

Identifiants

pubmed: 31794250
doi: 10.1259/bjr.20190615
pmc: PMC7055444
doi:

Types de publication

Evaluation Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

20190615

Références

Clin Radiol. 2011 Mar;66(3):291-3
pubmed: 21295211
Cardiovasc Intervent Radiol. 2017 Aug;40(8):1141-1146
pubmed: 28584945
Radiology. 2008 Mar;246(3):903-9
pubmed: 18195385
Insights Imaging. 2013 Apr;4(2):185-98
pubmed: 23247774
J Vasc Interv Radiol. 2002 Mar;13(3):317-20
pubmed: 11875092
Clin Radiol. 2017 Aug;72(8):626-635
pubmed: 28258743
Insights Imaging. 2017 Jun;8(3):357-363
pubmed: 28500486
J Vasc Interv Radiol. 2010 Jun;21(6):789-95
pubmed: 20307987
Int J Hyperthermia. 2018 Nov;34(7):1049-1052
pubmed: 28982246
Scand J Urol Nephrol. 2007;41(6):563-4
pubmed: 17853039
Semin Intervent Radiol. 2015 Jun;32(2):89-97
pubmed: 26038617
J Thorac Cardiovasc Surg. 2010 Nov;140(5):1196-7
pubmed: 20598324
AJR Am J Roentgenol. 2010 Mar;194(3):784-9
pubmed: 20173160
AJR Am J Roentgenol. 2011 Feb;196(2):W199-204
pubmed: 21257863
J Vasc Interv Radiol. 2018 Sep;29(9):1298-1300
pubmed: 30146203
J Vasc Interv Radiol. 2005 Mar;16(3):417-21
pubmed: 15758142
Bull Cancer. 2017 May;104(5):417-422
pubmed: 28477869
Int J Hyperthermia. 2017 Feb;33(1):34-42
pubmed: 27443519
Onco Targets Ther. 2018 Mar 13;11:1395-1402
pubmed: 29559797
Insights Imaging. 2014 Jun;5(3):339-46
pubmed: 24838839
Radiol Med. 2014 Jul;119(7):533-40
pubmed: 25001585
Eur Radiol. 2007 Dec;17 Suppl 6:F107-11
pubmed: 18376464
AJR Am J Roentgenol. 2005 Oct;185(4):878-84
pubmed: 16177404
Diagn Interv Imaging. 2015 Jul-Aug;96(7-8):833-40
pubmed: 26138359
J Clin Imaging Sci. 2016 Sep 19;6:34
pubmed: 27833776
J Vasc Interv Radiol. 2010 Apr;21(4):431-5
pubmed: 20346880
Cardiovasc Intervent Radiol. 2017 Oct;40(10):1501-1513
pubmed: 28523447
Eur J Surg Oncol. 2012 Mar;38(3):274-80
pubmed: 22209064
J Vasc Interv Radiol. 2004 Feb;15(2 Pt 1):183-7
pubmed: 14963187
J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S240-9
pubmed: 19394868

Auteurs

Tian'an Jiang (T)

Department of Diagnostic Ultrasound, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.

Alexis Kelekis (A)

2nd Department of Radiology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Qiyu Zhao (Q)

Department of Diagnostic Ultrasound, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.

Argyro Mazioti (A)

2nd Department of Radiology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Jia Liu (J)

Department of Diagnostic Ultrasound, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.

Nikolaos Kelekis (N)

2nd Department of Radiology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Guo Tian (G)

Department of Diagnostic Ultrasound, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.

Dimitrios Filippiadis (D)

2nd Department of Radiology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH